APPREPITANT PELLETS 40% W/W: (Apprepitant Enteric Coated pellets 40%w/w).

APPREPITANT PELLETS 40% W/W: (Apprepitant Enteric Coated pellets 40%w/w).
Product Description

Physical SpecificationsWhite to off while spherical pellets, Pellets Size: ASTM 16#24. Release specification: As per latest USP std, including additional parameters i.e. Related Substances (RS/impurities) and Microbiological (Ready To Fill size 1 and 2 Capsule, for Hard Gelatin Capsule formulation only)  Fill Weight:  For 80mg capsule: 200 mg pellets filled in SIZE 2 capsule. 1 kg of Pellets can be filled in 5000 capsules /kg pellets. For 125 mg capsule: 312 mg pellets filled in SIZE 1 capsule. 1 kg of Pellets can be filled in 3205 capsules /kg pellets. Mfg. Facility: Product is Mfg. under EU-GMP, WHO-GMP and Jordan-FDA approved GMP facility. Delivery Schedule:

Murli Krishna Pharma Pvt Ltd

  • IN
  • 2016
    On CPhI since
  • 2
    Certificates
  • 250 - 499
    Employees
Manufacturer/Innovator
Specifications

Murli Krishna Pharma Pvt Ltd

  • IN
  • 2016
    On CPhI since
  • 2
    Certificates
  • 250 - 499
    Employees
Manufacturer/Innovator

More Products from Murli Krishna Pharma Pvt Ltd

  • CLARITHROMYCIN MICRO PELLETS 27.5%W/W :(CLARITHROMYCIN Enteric Coated pellets 27.5%w/w)

    Product CLARITHROMYCIN MICRO PELLETS 27.5%W/W :(CLARITHROMYCIN Enteric Coated pellets 27.5%w/w)

    Physical Specifications: White to off white spherical pellets, Pellets Size: ASTM 30#80. Release specification: As per latest USP std, including additional parameters i.e. Related Substances (RS/impurities) and Microbiological (Ready To Fill size 0 Capsule, for Hard Gelatin Capsule formulation only)  Fill Weight:  For 250mg capsule: 909mg pellets filled in SIZE 0capsule. 1 kg of Pellets can be filled in 1100 capsules /kg pellets  
  • CLARITHROMYCIN MICRO PELLETS 42%W/W : (CLARITHROMYCIN Enteric Coated pellets 42%w/w)

    Product CLARITHROMYCIN MICRO PELLETS 42%W/W : (CLARITHROMYCIN Enteric Coated pellets 42%w/w)

    CLARITHROMYCIN MICRO PELLETS 42%W/W : (CLARITHROMYCIN Enteric Coated pellets 42%w/w) 

    Physical Specifications: White to off while spherical pellets, Pellets Size: ASTM 30#80.

    Release specification: As per latest USP std, including additional parameters i.e. Related Substances (RS/impurities) and Microbiological

    (Ready To Fill size 0 Capsule, for Hard Gelatin Capsule formulation only)

    Fill Weight: 

    For 250mg capsule: 595mg pellets filled in SIZE 0capsule. 1 kg of Pellets can be filled in 1680 capsules /kg pellets. 

     

    Mfg. Facility: Product is Mfg. under EU-GMP, WHO-GMP and Jordan-FDA approved GMP facility.

     

    Product Packing:

    25kg product packing in 25kg HDPE drums with double sealed poly bag inside along desiccants.

    Data loggers will be provide in the drum if required.(For temp. monitoring during transit)

     

    Delivery Schedule:For regular specs.-14 working days from the date of confirming the PO. (+/- 4days for customized specs).

     

    Payment Terms: Advance, by TT / L/C at sight / TT100% against scan shipping documents.

     

    MOQ: 100kg and 200kgs / order. (Max. mfg. capacity / month: 10MT)

     

    Documentation: DMF in CTD format is available.(for pellets) 3.2.P

  • ITRACONAZOLE PELLETS 22% W/W:

    Product ITRACONAZOLE PELLETS 22% W/W:

    ITRACONAZOLE PELLETS 22% W/W:

    Specifications: White to off white spherical pellets,
    Pellets Size:  ASTM16#20: 
    Release specification: As per latest USP std.
    Fill Weight: 
    For 100mg capsule: 455mg pellets filled in SIZE 0 capsules. 1 kg of Pellets can be filled in 2197 capsules.
    Mfg. Facility:         

    Product is Mfg. under EU-GMP, WHO-GMP and Jordan-FDA approved GMP facility.
    Product Packing:

    25kg product packing in 25kg HDPE drums with double sealed poly bags inside.
    Delivery Schedule

    21 days from the date of confirming the PO.
    Documentation: DMF in CTD format is available. 



     

     

  • LANSOPRAZOLE Micro PELLETS 12.5%W/W: (Lansoprazole Enteric Coated Micro pellets 12.5%)

    Product LANSOPRAZOLE Micro PELLETS 12.5%W/W: (Lansoprazole Enteric Coated Micro pellets 12.5%)

    LANSOPRAZOLE Micro PELLETS 12.5%W/W: (Lansoprazole Enteric Coated Micro pellets 12.5%)

    Physical Specifications: White to off while spherical pellets, Pellets Size: ASTM 30#50, ASTM 25#50

    Release specification: As per latest USP std. including additional parameters i.e. Related Substances (RS/impurities) and Microbiological

    (Ready To compress for Tablet formulation only) 

    Fill Weight:  for 30mg:
    Mfg. Facility: Product is Mfg. under EU-GMP, WHO-GMP and Jordan-FDA approved GMP facility.

    Product Packing:
    25kg product packing in 25kg HDPE drums with double sealed poly bag inside along desiccants.

    Data loggers will be provide in the drum if required.(For temp. monitoring during transit) 

    Delivery Schedule: For regular specs.-14 working days from the date of confirming the PO. (+/- 4days for customized specs)

    Payment Terms: Advance, by TT / L/C at sight / TT100% against scan shipping documents. 

    MOQ: 100kg and 200kgs / order. (Max. mfg. capacity / month: 8MT)

    Documentation: DMF in CTD format is available for, pellets 3.2.P

     

     

  • Lansoprazole Pellets 8.5%

    Product Lansoprazole Pellets 8.5%

    We Murli Krishna Pharma specialised in the manufacture of Pharmaceutical Pellets/ Micro Pellets / Granules and MUPS.We manufacture Lansoprazole Pellets 8.5%( Product complies to USP) Particle size:  ( 14 #18), ( 16 #20) and ( 30 #80) Comparative Dissolution:  The profile matches to the innovator profile.
  • Omeprazole PELLETS 8.5%W/W: (OmeprazoleEnteric Coated pellets 8.5%w/w)

    Product Omeprazole PELLETS 8.5%W/W: (OmeprazoleEnteric Coated pellets 8.5%w/w)

    Omeprazole PELLETS 8.5%W/W: (OmeprazoleEnteric Coated pellets 8.5%w/w)


    Physical Specifications: 

    White to off while spherical pellets, Pellets Size: ASTM 14#18.

    Release specification: As per latest USP std. including additional parameters i.e. Related Substances (RS/impurities) and

    Microbiological

    (Ready To Fill size 0, 2 & 4 Capsule, for Hard Gelatin Capsule formulation only) 

    Fill Weight: 

    For 40mg capsule: 471mg pellets filled in SIZE 0 capsule. 1 kg of Pellets can be filled in 2123 capsules /kg pellets.

    For 20mg capsule: 235mg pellets filled in SIZE 2 capsule. 1 kg of Pellets can be filled in 4255capsules /kg pellets.

    For 10mg capsule: mg pellets filled in SIZE 4 capsule. 1 kg of Pellets can be filled in 8474capsules /kg pellets. 

    Mfg. Facility: Product is Mfg. under EU-GMP, WHO-GMP and Jordan-FDA approved GMP facility. 

    Product Packing:

    25kg product packing in 25kg HDPE drums with double sealed poly bag inside along desiccants.

    Delivery Schedule:For regular specs.-14 working days from the date of confirming the PO. (+/- 4days for customized specs)

    Payment Terms: Advance, by TT / L/C at sight / TT100% against scan shipping documents.

    MOQ: 200kg and 500kgs / order. (Max. mfg. capacity / month: 10MT)

    Documentation: DMF in CTD format is available.(for pellets) 3.2.P

     

     

  • Azithromycin Taste Masked Pellets

    Product Azithromycin Taste Masked Pellets

    The objective of developing Azithromycin taste masked micro pellets (Multiple unit particulate system i.e. MUPS) by aqueous technology is to fill the micro pellets in to capsule, are compressed into tablet and also are constituted to make the oral suspension.
  • Brinzolamide

    Product Brinzolamide

    MKPPL developed a Nano particle based matrix which can deliver hydrophilic as well as hydrophobic drugs using a combination of hydrophilic and hydrophobic excipients as a clear solution. This cogent use of excipients ensures that the drug is absorbed optimally and the Nano particles ensure that the drug penetrates not only through the hydrophobic and hydrophilic channels but also through the OraSerrata which protects the eye from any foreign body entering the optical cavity.
  • Budesonide

    Product Budesonide

    There is a potential for the development of inhalation medicines in lipid Nano particles to possess controlled release properties. MKPPL’s Budesonide suspension has been developed in a complete aqueous base using a couple of specialized solubilizers which also helps in the Nano encapsulation of the drug.
  • Dexlansoprazole Pellets

    Product Dexlansoprazole Pellets

    The pharmaceutical form of dexlansoprazole is based on the unique technology of modified dual release. The active ingredient is released in two phases at different pH values and with a time interval. Consequently, the drug achieves two peak concentrations in the blood, and the total serum concentration of dexlansoprazole is three times higher than that of the left-handed enantiomer.
  • Duloxetine

    Product Duloxetine

    The objective is to develop Duloxetine DR pellets by aqueous technology. Pellets developed by aqueous technology have advantage of avoiding the use of organic solvents
  • Erlotinib MUPS, Granules

    Product Erlotinib MUPS, Granules

    Murli Krishna Pharma developed a Nano particle based premix for direct compression into tablets. The premix was developed using the following approach: 1)            Enhance the solubility of Erlotinib at near neutral pH. 2)            Development of polymer encapsulated Nano particle solution of Erlotinib.

Murli Krishna Pharma Pvt Ltd resources

  • News Murli Krishna Pharma Pvt at CPHI North America

    We are pleased announce we are participating in CPHI North America 2019.
  • News CphI W/W-2019-Frankfurt-our stall details

    We are please to inform that, we are participating in CPhI W/W 2019 at Frankfurt
    Visit us at :  CPHI Worldwide, Frankfurt, Germany ( 5-7 Nov, 2019) @ Hall: 4.1-B(IP-06)
  • Brochure Corporate Brochure

    Murli Krishna Pharma Pvt Ltd is a young and dynamic Novel Drug Delivery Systems (NDDS) organization that provides a range of effective solutions to optimize the delivery of pharmaceutical products. Our current activities include manufacturing of pre-finished formulations i.e. Pellets, Granules and MUPS using Aqueous Based technology, Nano Particles and Transdermal Oil.

  • Brochure Tamsulosin HCL SR Pellets 0.125%, 0.13%, 0.16%, 0.20%

    Tamsulosin HCL SR pellets is developed using an Aqueous platform and our USP lies in complying with all the US Pharmacoepial specifications. With a formulation that is in line with the Innovator product in terms of release profile, We extensively use Extrusion spheronization process besides the wurster process
  • Video Nab Paclitaxel (Albumin Bound)

    Murli Krishna Pharma is one of the few companies from India who have developed Albumin bound Paclitaxel. The particle size and the encapsulation efficiency have matched with the innovator’s specifications. In Vitro Cell line studies have shown that the activity is comparable to the innovator.
  • Video Orlistat Pellets 50%

    Leading Manufacturer from India for Orlistat pellets. Offering a product matching the Innovator's release profile, our product does not infringe with the patent.
  • Video Iron & Vitamin Liposomal Transdermal

    A Topical administration route had been chosen for the first time for Iron and Vitamins. With Minimal to Zero side effects, the absorption is almost close to 60% when compared to that of the oral route where the absorption is less than 20%. With a strong back up of clinicals on infants, this product of Murli Krishna Pharma is in the process of getting patented

Recommended products